STORY FROM: Drugs & Medical Devices
Design Defect Claim to Proceed in La. Abilify Tardive Dyskinesia Case
June 30, 2016
BATON ROUGE, La. — A Louisiana federal judge has allowed a design defect to proceed in an Abilify tardive dyskinesia case, holding that the plaintiff has sufficiently alleged the existence of an alternative design that would not have caused him to contract the disorder.
However, in the June 28 order, Judge Shelly Dick of the U.S. District Court for the Middle District of Louisiana dismissed the plaintiff’s redhibition claim, finding he was clearly notified that Abilify had the potential to cause TD and that the drug’s warning also explained TD and its symptoms.
Raymond Crochet allegedly contracted TD, a ...
Associated Law Firms
Baker Donelson Bearman Caldwell & Berkowitz
Irwin Fritchie Urquhart & Moore
Winston & Strawn